CDC25C and glioblastoma: Particularly, SSTRs, which mediate the antiproliferative activity of somatostatin in GBM cells [41, 42], can be targeted by specific agonists that, via the activation of specific phosphotyrosine phosphatases [43], exert both cytostatic and antiangiogenic effects in in vivo GBM mouse models [44].